Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Moesin expression by tumor cells is an unfavorable prognostic biomarker for oral cancer

Texto completo
Autor(es):
Abreu Barros, Francisco Barbara [1] ; Assao, Agnes [1] ; Garcia, Natalia Galvao [1] ; Nonogaki, Suely [2] ; Carvalho, Andre Lopes [3] ; Soares, Fernando Augusto [4] ; Kowalski, Luiz Paulo [5] ; Oliveira, Denise Tostes [1]
Número total de Autores: 8
Afiliação do(s) autor(es):
[1] Univ Sao Paulo, Bauru Sch Dent, Area Pathol, Dept Stomatol, Alameda Octavio Pinheiro Brisolla 9-75, BR-17012901 Bauru, SP - Brazil
[2] Adolfo Lutz Inst, Pathol Div, Sao Paulo - Brazil
[3] Canc Hosp Barretos, Fundacao Pio Inst 12, Barretos, SP - Brazil
[4] Rede DOr Hosp Network, Pathol Div, Sao Paulo - Brazil
[5] AC Camargo Canc Ctr Hosp, Dept Head & Neck Surg & Otorhinolaringol, Sao Paulo - Brazil
Número total de Afiliações: 5
Tipo de documento: Artigo Científico
Fonte: BMC CANCER; v. 18, JAN 8 2018.
Citações Web of Science: 4
Resumo

Background: Moesin is a member of the ERM (ezrin, radixin and moesin) proteins that participate in cell migration and tumor invasion through transductional signals sent to actin filaments by glycoproteins, such as podoplanin. Methods: This study aimed to evaluate the participation of moesin and podoplanin in the invasive tumor front of oral squamous cell carcinomas, and their influence on patients' prognosis. Podoplanin and moesin immunoexpressions were evaluated by a semi-quantitative score method, based on the capture of 10 microscopic fields, at 400X magnification, in the invasive tumor front of oral squamous cell carcinomas. The association of moesin and podoplanin expression with clinicopathological variables was analyzed by the chi-square, or Fisher's exact test. The 5 and 10 years survival rates were calculated by the Kaplan-Meier method and the survival curves were compared by using the log-rank test. Results: The immunohistochemical expression of moesin in the invasive front of oral squamous cell carcinomas was predominantly strong, homogenously distributed on the membrane and in the cytoplasm of tumor cells. The expression of moesin was not associated with clinical, demographic and microscopic features of the patients. Otherwise, podoplanin expression by malignant epithelial cells was predominantly strong and significantly associated with radiotherapy (p = 0.004), muscular invasion (p = 0.006) and lymph node involvement (p = 0.013). Strong moesin expression was considered an unfavorable prognostic factor for patients with oral squamous cell carcinomas, clinical stage II and III (p = 0.024). Conclusions: These results suggested that strong moesin expression by malignant cells may help to determine patients with oral squamous cell carcinoma and poor prognosis. (AU)

Processo FAPESP: 12/13411-6 - Participação da podoplanina no processo de remodelação celular em tumores odontogênicos benignos e tumores epiteliais malignos de boca
Beneficiário:Denise Tostes Oliveira
Modalidade de apoio: Auxílio à Pesquisa - Regular